Literature DB >> 2788284

Fibroblast interleukin 1 beta: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation.

J A Elias1, M M Reynolds, R M Kotloff, J A Kern.   

Abstract

To understand the role fibroblasts play in mediating and amplifying the effects of inflammatory cytokines, we determined whether recombinant interleukin 1 (IL-1) and recombinant tumor necrosis factor (TNF), alone and in combination, stimulated fibroblasts to produce IL-1 beta. Recombinant IL-1 (alpha and beta) stimulated fibroblast IL-1 beta mRNA accumulation, whereas recombinant TNF did not. In addition, simultaneous stimulation with recombinant IL-1 (alpha or beta) and recombinant TNF resulted in a synergistic increase in IL-1 beta mRNA levels. However, in all cases, IL-1 beta mRNA accumulation was not associated with fibroblast production of soluble IL-1 beta protein. Lysates of unstimulated, recombinant IL-1-stimulated, and recombinant TNF-stimulated fibroblasts did not contain IL-1 beta prohormone. In contrast, IL-1 beta prohormone was detected in lysates of fibroblasts incubated simultaneously with recombinant IL-1 and recombinant TNF. These studies demonstrate that recombinant IL-1 stimulates fibroblast IL-1 beta mRNA accumulation and that recombinant IL-1 and recombinant TNF synergize to further up-regulate IL-1 beta mRNA levels. In addition, they show that IL-1 beta production by human lung fibroblasts is inhibited at a posttranscriptional level. Translational control appears to be important in recombinant IL-1-stimulated fibroblasts and posttranslational control is important in fibroblasts stimulated simultaneously with recombinant IL-1 and recombinant TNF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788284      PMCID: PMC297799          DOI: 10.1073/pnas.86.16.6171

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain.

Authors:  M L Chu; J C Myers; M P Bernard; J F Ding; F Ramirez
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

3.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

Review 4.  An update on human interleukin-1: from molecular biology to clinical relevance.

Authors:  C A Dinarello
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

5.  Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.

Authors:  G Scala; J J Oppenheim
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

6.  Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.

Authors:  T Kasahara; N Mukaida; K Hatake; K Motoyoshi; T Kawai; K Shiori-Nakano
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity.

Authors:  J A Elias; A D Schreiber; K Gustilo; P Chien; M D Rossman; P J Lammie; R P Daniele
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Production of interleukin 1 by human endothelial cells.

Authors:  P Miossec; D Cavender; M Ziff
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

9.  Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.

Authors:  M D Wewers; S I Rennard; A J Hance; P B Bitterman; R G Crystal
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process.

Authors:  J A Elias; M D Rossman; R B Zurier; R P Daniele
Journal:  Am Rev Respir Dis       Date:  1985-01
View more
  17 in total

Review 1.  Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations.

Authors:  T S Kupper
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes.

Authors:  S S Sung; J A Walters
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection.

Authors:  L H Thomas; M I Wickremasinghe; M Sharland; J S Friedland
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Removal of a 3' non-coding sequence is an initial step in degradation of gro alpha mRNA and is regulated by interleukin-1.

Authors:  M Y Stoeckle
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

6.  IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis.

Authors:  Y Kawaguchi
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

7.  Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.

Authors:  E V Granowitz; B M Saget; M Z Wang; C A Dinarello; P R Skolnik
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

8.  Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression.

Authors:  B C Marshall; A Santana; Q P Xu; M J Petersen; E J Campbell; J R Hoidal; H G Welgus
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells.

Authors:  C G Gay; J A Winkles
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 10.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.

Authors:  M N Sheppard; N K Harrison
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.